128 related articles for article (PubMed ID: 21951998)
21. T315 Decreases Acute Myeloid Leukemia Cell Viability through a Combination of Apoptosis Induction and Autophagic Cell Death.
Chiu CF; Weng JR; Jadhav A; Wu CY; Sargeant AM; Bai LY
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27537872
[TBL] [Abstract][Full Text] [Related]
22. Iron chelation in the treatment of cancer: a new role for deferasirox?
Bedford MR; Ford SJ; Horniblow RD; Iqbal TH; Tselepis C
J Clin Pharmacol; 2013 Sep; 53(9):885-91. PubMed ID: 23740857
[TBL] [Abstract][Full Text] [Related]
23. Deferasirox reduces iron overload in a murine model of juvenile hemochromatosis.
Nick H; Allegrini PR; Fozard L; Junker U; Rojkjaer L; Salie R; Niederkofler V; O'Reilly T
Exp Biol Med (Maywood); 2009 May; 234(5):492-503. PubMed ID: 19234060
[TBL] [Abstract][Full Text] [Related]
24. Antitumor activity of sorafenib in FLT3-driven leukemic cells.
Auclair D; Miller D; Yatsula V; Pickett W; Carter C; Chang Y; Zhang X; Wilkie D; Burd A; Shi H; Rocks S; Gedrich R; Abriola L; Vasavada H; Lynch M; Dumas J; Trail PA; Wilhelm SM
Leukemia; 2007 Mar; 21(3):439-45. PubMed ID: 17205056
[TBL] [Abstract][Full Text] [Related]
25. Oral iron chelation and the treatment of iron overload in a pediatric hematology center.
Raphael JL; Bernhardt MB; Mahoney DH; Mueller BU
Pediatr Blood Cancer; 2009 May; 52(5):616-20. PubMed ID: 19148949
[TBL] [Abstract][Full Text] [Related]
26. DMNQ-S17 inhibits constitutive NF-kappaB activation leading to induction of apoptosis through the activation of caspase-3 in human myeloid leukemia U937 cells.
Park MJ; Kwon HY; Lee EO; Lee HJ; Ahn KS; Kim MO; Kim CH; Ahn KS; Kim SH
Life Sci; 2008 Sep; 83(13-14):460-7. PubMed ID: 18718843
[TBL] [Abstract][Full Text] [Related]
27. Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.
Hossain MA; Kim DH; Jang JY; Kang YJ; Yoon JH; Moon JO; Chung HY; Kim GY; Choi YH; Copple BL; Kim ND
Int J Oncol; 2012 May; 40(5):1636-42. PubMed ID: 22322725
[TBL] [Abstract][Full Text] [Related]
28. STI-571 (imatinib mesylate) enhances the apoptotic efficacy of pyrrolo-1,5-benzoxazepine-6, a novel microtubule-targeting agent, in both STI-571-sensitive and -resistant Bcr-Abl-positive human chronic myeloid leukemia cells.
Greene LM; Kelly L; Onnis V; Campiani G; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2007 Apr; 321(1):288-97. PubMed ID: 17202400
[TBL] [Abstract][Full Text] [Related]
29. Failure of deferasirox, an iron chelator agent, combined with antifungals in a case of severe zygomycosis.
Soummer A; Mathonnet A; Scatton O; Massault PP; Paugam A; Lemiale V; Mira JP; Dannaoui E; Cariou A; Lortholary O
Antimicrob Agents Chemother; 2008 Apr; 52(4):1585-6. PubMed ID: 18212106
[No Abstract] [Full Text] [Related]
30. Iron chelators induce autophagic cell death in multiple myeloma cells.
Pullarkat V; Meng Z; Donohue C; Yamamoto VN; Tomassetti S; Bhatia R; Krishnan A; Forman SJ; Synold TW
Leuk Res; 2014 Aug; 38(8):988-96. PubMed ID: 24998390
[TBL] [Abstract][Full Text] [Related]
31. Curcumin induces cell cycle arrest and apoptosis in human osteosarcoma (HOS) cells.
Lee DS; Lee MK; Kim JH
Anticancer Res; 2009 Dec; 29(12):5039-44. PubMed ID: 20044614
[TBL] [Abstract][Full Text] [Related]
32. Iron overload induces apoptosis of murine preosteoblast cells via ROS and inhibition of AKT pathway.
Ke JY; Cen WJ; Zhou XZ; Li YR; Kong WD; Jiang JW
Oral Dis; 2017 Sep; 23(6):784-794. PubMed ID: 28248443
[TBL] [Abstract][Full Text] [Related]
33. Inconsistent hepatic antifibrotic effects with the iron chelator deferasirox.
Sobbe A; Bridle KR; Jaskowski L; de Guzman CE; Santrampurwala N; Clouston AD; Campbell CM; Subramaniam VN; Crawford DH
J Gastroenterol Hepatol; 2015 Mar; 30(3):638-45. PubMed ID: 25168203
[TBL] [Abstract][Full Text] [Related]
34. [Construction of autocatalytic caspase-3 and its effects of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K
Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):846-51. PubMed ID: 18476520
[TBL] [Abstract][Full Text] [Related]
35. WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells.
Wosikowski K; Mattern K; Schemainda I; Hasmann M; Rattel B; Löser R
Cancer Res; 2002 Feb; 62(4):1057-62. PubMed ID: 11861382
[TBL] [Abstract][Full Text] [Related]
36. Long-term efficacy and safety of deferasirox.
Cappellini MD
Blood Rev; 2008 Dec; 22 Suppl 2():S35-41. PubMed ID: 19059055
[TBL] [Abstract][Full Text] [Related]
37. Z-ajoene induces apoptosis of HL-60 cells: involvement of Bcl-2 cleavage.
Li M; Min JM; Cui JR; Zhang LH; Wang K; Valette A; Davrinche C; Wright M; Leung-Tack J
Nutr Cancer; 2002; 42(2):241-7. PubMed ID: 12416266
[TBL] [Abstract][Full Text] [Related]
38. Homoharringtonine mediates myeloid cell apoptosis via upregulation of pro-apoptotic bax and inducing caspase-3-mediated cleavage of poly(ADP-ribose) polymerase (PARP).
Yinjun L; Jie J; Weilai X; Xiangming T
Am J Hematol; 2004 Jul; 76(3):199-204. PubMed ID: 15224352
[TBL] [Abstract][Full Text] [Related]
39. Monitoring long-term efficacy of iron chelation treatment with biomagnetic liver susceptometry.
Fischer R; Piga A; Harmatz P; Nielsen P
Ann N Y Acad Sci; 2005; 1054():350-7. PubMed ID: 16339683
[TBL] [Abstract][Full Text] [Related]
40. Increased serum hepcidin levels during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndrome.
Ghoti H; Fibach E; Westerman M; Gordana O; Ganz T; Rachmilewitz EA
Br J Haematol; 2011 Apr; 153(1):118-20. PubMed ID: 21332711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]